Testis dysgenesis and decreased reproductive parameters after prenatal exposure to DEHP. by Ludwig Stenz (779897)

A decreased expression of Rab4b increased GLUT4 localization at the plasma membrane. by Vincent Kaddai (264976)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

A blue-shifted fluorescence donor increases fAP amplitude but exhibits a decreased SNR. A. by Ann E. Fink (312543)

S100A7-downregulated cells decrease osteoclast formation and IL-8 expression levels. by Vikram Paruchuri (87721)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Anti-estrogens Tamoxifen and Fulvestrant decrease Mcl-1 mRNA expression. by Jennifer L. Schacter (589790)

Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

“…The average of 25 OD readings obtained for each of the Capzb2 concentrations examined was normalized against the average OD reading in the absence of Capzb2 during 750–1,500-s interval (darkly shaded in [E]) in which the final extent of tubulin polymerization is achieved for a given reaction. Capzb2 concentration is displayed on a log of 10 scale, so the first depicted point (tubulin polymerization in the absence of Capzb2; OD value = 100%) on the obtained nonlinear sigmoidal curve (<i>R</i>² = 0.99) corresponds to 0.01 on the Log Capzb2 (µM). …”

Knockdown of ERα results in decrease in Mcl-1 mRNA expression. by Jennifer L. Schacter (589790)

Effects of bFGF on decrease of HG-induced accumulation of intracellular ROS levels. by Yuan Hu Xuan (632639)

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”

AtCaM4 decreases GSNOR activity in response to salt stress. by Shuo Zhou (1320660)

Less Iso-induced decrease of τ in female hearts. by Gregory S. Hoeker (650231)

“…B) Sex differences in the decrease in τ (versus baseline values) as a function of the dose of Iso (1, 10, 31.6, 100, 316.2 nM) in the LV base <i>(left)</i> and apex <i>(right)</i> of female (n = 5) and male (n = 5) hearts with pacing at 3 (<i>top</i>) and 5.5 Hz (<i>bottom</i>). …”

Treatment with Gr1+ depleting antibody results in significant decrease in lung neutrophils. by Dongwan D. Kang (357725)

AKP-11 decreases cell surface expression of S1P1 receptor. by Devadoss J. Samuvel (327215)

Inhibition of <i>de novo</i> lipogenesis decreases intracellular HCV RNA. by Sowmya Narayanan (2826308)

TL decreases cell viability in malignant cells dependent of p53 status. by Ajay Kumar (192967)

TH588 effectively decreases cellular survival in heterogeneous neuroendocrine tumor cells. by Elke Tatjana Aristizabal Prada (833927)

Paclitaxel decreases average neurite outgrowth but not viability of iPSC-dSN. by Geneva M. Cunningham (11909900)